| Model Number |
11Y90R3 |
| Medical Device Problem Codes |
Crack (1135); Fluid/Blood Leak (1250); Material Puncture/Hole (1504)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
03/19/2025
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Event or Problem Description
|
|
It was reported that there was a leak/cut in the custom tubing pack, specifically in the 3/8 x 3/32 segment of tubing prior to use.The leak/cut was were the tubing is marked by red tape.The same leak did not appear in multiple packs.The customer stated that patient blood loss did not occur because of the leak and an unplanned blood transfusion was not required because of the blood loss from the leak the device was replaced to complete the case.There was no patient involved.
|
| |
|
Additional Manufacturer Narrative
|
|
Device evaluation summary: visual inspection shows evidence of damage/cut in a section of the tubing.Unit appears to have been primed.Pressure integrity testing was performed at 3 l/pm with 23 psi, (1189 mmhg) of back pressure for 10 minutes.During the pressure integrity testing there was a leak observed from the damage/cut.Reason for return was confirmed.Correction h6.1: device codes (fdd/annex a): this field has been updated.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Additional Manufacturer Narrative
|
|
Additional information b5.Medtronic received additional information that the tubing was partially cut.The tubing leaked during priming.There was no visible air in system/tubing.There was no damage to the packaging (outer box, inner packaging or sterile barrier) no damage to the packaging.There was no damage to any of the other components.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Search Alerts/Recalls
|